Journal of Medicinal Chemistry p. 1962 - 1969 (1990)
Update date:2022-08-02
Topics:
Rosenberg, Saul H.
Woods, Keith W.
Sham, Hing L.
Kleinert, Hollis D.
Martin, Donald L.
et al.
Incorporation of nonreactive polar functionalities at the C- and N-termini of renin inhibitors led to the development of a subnanomolar compound (21) with millimolar solubility.This inhibitor demonstrated excellent efficacy and a long duration of action upon intravenous administration to monkeys.While activity was also observed intraduodenally, a comparison of the blood pressure responses indicated low bioavailability.Subsequent experiments in rats showed that, although the compound was absorbed from the gastrointrestinal tract, extensive liver extraction severely limited bioavailability.
View MoreWuhan Jing Chu Chen Pharmaceutical Chemical Co., Ltd.
Contact:027-88877050
Address:Wuhan
MTT Pharma & Bio-technology Co.,Ltd(expird)
Contact:+86-21-58407925
Address:Room2019, Building C, Tomson Center, No.158, Zhang Yang Road, Shanghai, China
Hangzhou Haiqiang Chemical Co.,Ltd.
Contact:+86-571-86960370
Address:Add: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China
Contact:+86-571-87010026
Address:202, Zhenhua Road,
Weifang Adde Economic And Trade Co.,LTD.
Contact:86-536-8885548
Address:Room 1402,Wanda Plaza B Block,No.958,Yuanfei Road,Kuiwen District
Doi:10.1007/s11172-013-0117-y
(2013)Doi:10.1016/j.molstruc.2003.10.049
(2004)Doi:10.1002/ardp.201200038
(2012)Doi:10.1016/j.molstruc.2009.12.043
(2010)Doi:10.1016/j.tetlet.2010.02.163
(2010)Doi:10.1016/j.jfluchem.2010.11.004
(2011)